Primary Care Coding Alert

Report Combination Nebulizer Medication With 2 New J Codes

Surprise: Premixed means the same thing as compounded HCPCS 2005 adds two new compound inhalation solution codes that you may use - even when your office premixes the drugs. Choose From 6 New Nebulizer Med Codes This year you have two new codes for compounded inhalation solution:
  J7616 - Albuterol, up to 5 mg and ipratropium bromide, up to 1 mg, compounded inhalation solution, administered through DME
  J7617 - Levalbuterol, up to 2.5 mg and ipratropium bromide, up to 1 mg, compounded inhalation solution, administered through DME.
 
HCPCS 2005 introduces J7616-J7617, along with J codes for albuterol:
  J7611 - Albuterol, inhalation solution, administered through DME, concentrated
form, 1 mg
  J7613 - Albuterol, inhalation solution, administered through DME, unit dose, 1 mg and levalbuterol:  J7612 - Levalbuterol, inhalation solution, administered through DME, concentrated form, 0.5 mg
  J7614 - Levalbuterol, inhalation solution, administered through DME, unit dose,
0.5 mg. More nebulizer news: The March 2005 Family Practice Coding Alert article on new inhalation J codes discusses the four individual nebulizer medication codes (J7611-J7614) that replace albuterol and levalbuterol codes J7618 and J7619.
 
The article, however, didn't mention albuterol/levalbuterol with ipratropium bromide codes J7616 and J7617, says Angela McDougal, CCS-P, coding analyst at Bend Memorial Clinic in Bend, Ore.

Old way: When a family physician (FP) administered a nebulizer treatment containing a compounded inhalation solution of albuterol and levalbuterol, you should have assigned J7621 (Albuterol, all formulations, including separated isomers, up to 5 mg [albuterol] or 2.5 mg [levalbuterol], and ipratropium bromide, up to 1 mg, compounded inhalation solution, administered through DME). HCPCS 2005 deletes this J code.

New way: You should now specify whether the FP uses a compounded inhalation solution of:  albuterol and ipratropium bromide - J7616
  levalbuterol and ipratropium bromide - J7617. Bill Premixed Solution With Compounded Code Codes J7616 and J7617 may come in handy more than you think. Even if you premix albuterol/levalbuterol and ipratropium bromide, you should still use these new compounded inhalation solution J codes, says Kent J. Moore, manager of Health Care Financing and Delivery Systems for the American Academy of Family Physicians in Leawood, Kan.

Reason: "Medicare implies that premixed and compounded are synonymous," Moore says. In the 2005 fee schedule proposed rule (see page 61 of the document at www.cms.hhs.gov/providers/drugs/mpfs_05pr.pdf) CMS talks about suppliers furnishing albuterol and ipratropium bromide in "a premixed form (either commercially premixed or pharmacy-compounded)."

"So if a physician's office (like a pharmacy) mixes the two and administers them, they should use the compounded inhalation solution codes: J7616 or J7617,"  Moore says.

Example: "We mix levalbuterol and ipratropium bromide solutions ourselves," McDougal says. The clinic orders premixed albuterol and ipratropium bromide.

The clinic should use the compounded codes for either solution (J7616-J7617), rather than the component codes, [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Primary Care Coding Alert

View All